Rationale: People with cystic fibrosis (CF) generate Pseudomonas aeruginosa in droplet nuclei during coughing. The use of surgical masks has been recommended in healthcare settings to minimize pathogen transmission between patients with CF.
Pseudomonas aeruginosa is the dominant pathogen in the airways of people with cystic fibrosis (CF), with a prevalence of up to 70% in adults (1) (2) (3) . Chronic P. aeruginosa infection is associated with pulmonary function decline, increased exacerbations, poorer health-related quality of life, and reduced survival (4) (5) (6) . Studies have demonstrated that unrelated people with CF can harbor genetically indistinguishable strains, suggesting person-to-person spread of P. aeruginosa (7) (8) (9) (10) (11) . Consequently, CF infection control guidelines published in 2003 sought to minimize the potential contact and droplet transmission of pathogens and recommended cohort segregation according to microbiological status, single-room inpatient accommodation, and a separation distance of 1 meter between people with CF (12) . Although such measures are thought to have contributed to a reduction in epidemic P. aeruginosa (13) and Burkholderia cenocepacia strain acquisition (14) , crossinfection with CF pathogens has continued (11, 15, 16) .
Airborne transmission of P. aeruginosa was first suggested as a possible mode of cross-infection on the basis of studies in which researchers assessed environmental air contamination in CF clinical care settings (17) and cough aerosols from people with CF (18) . Particle size diameter is used to categorize respiratory aerosols into droplets (.5 mm) and droplet nuclei (<5 mm), with the latter being a consequence of droplet evaporation and capable of airborne transmission (19) . Our earlier work demonstrated that cough-generated droplet nuclei containing P. aeruginosa in the respirable size range remained viable for up to 45 minutes and were detected up to 4 meters from the source (20) . The updated CF infection control guidelines published in 2014 recommended a separation distance of 2 meters and included the specific recommendation for people with CF to wear a surgical mask in communal areas of healthcare facilities (21) .
Face masks and cough etiquette (i.e., coughing into the hand or arm) are strategies that may interrupt aerosol dispersal. The primary role of the surgical mask is to prevent contamination of the environment by infectious droplets. The relatively low efficiency capture of aerosols, particularly during coughing, and incomplete seal may allow particles to escape around the perimeter (22) . The N95 mask provides inward protection from inhaled airborne pathogens, and it is reasonable also to expect limitation of aerosolized infectious material generated by the wearer. To date, there is limited evidence of outward protection by surgical and N95 masks, and the tolerability of these interventions has not been widely studied in patients with lung disease. Therefore, the aim of this study was to determine and compare the effectiveness and comfort of two commonly used face masks and cough etiquette on the dispersal of aerosolized P. aeruginosa during talking and coughing in adults with CF. Some of the results of this study were previously reported in the form of an abstract (23) .
Methods
See online supplement for additional details.
Participants
Participants (n = 25) were recruited from The Prince Charles Hospital (TPCH) Adult Cystic Fibrosis Centre (ACFC), Brisbane, Australia, in 2015. Eligible participants had a confirmed CF diagnosis, were aged 18 years and older, and had chronic P. aeruginosa infection as determined by the modified Leeds criteria (3) . Exclusion criteria comprised recent hemoptysis (.50 ml), pneumothorax, pregnancy, and cough syncope. Written informed participant consent was obtained, and the study was approved by the local ethics committee.
Aerosol Sampling System
Using a validated, closed wind tunnel system, viable aerosols were collected at 2 meters from participants (24) . The sampling distance was defined in accordance with the current Cystic Fibrosis Foundation Infection Prevention and Control Guidelines recommending a 2-meter between-person separation (21) . Seated participants were positioned with their head within the tunnel with a weighted material cover rested over the shoulders and a slight positive tunnel pressure applied to prevent room air contamination (20) .
Aerosol Sampling Protocol
Participants completed six maneuvers on a single day: 1) talking, 2) talking wearing a tied surgical mask (TECNOL Fluidshield Fog-Free Surgical Mask; Kimberly-Clark Professional), 3) uncovered coughing (reference maneuver), 4) coughing wearing a tied surgical mask, 5) coughing wearing an N95 mask (N95 Particulate Filter Respirator; Kimberly-Clark), and 6) coughing with their hand covering their mouth (cough etiquette). The testing order of the uncovered cough maneuver, coughing wearing a surgical mask, and coughing wearing an N95 mask were randomized to minimize potential bias in aerosol production resulting from fatigue and airway clearance with repeated coughing (25) . For logistical reasons, the cough etiquette test was the final maneuver performed, and participants were asked to adopt their usual mouth-covering technique. A glove was worn on the cough-covering hand to minimize microbial dispersal from skin. Participants rested for at least 20 minutes between each maneuver. Face masks were sized and applied by a trained healthcare professional. 
At a Glance Commentary
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Within the tunnel, each participant completed 2 minutes of tidal breathing in filtered, high-efficiency particulate air to wash out residual room air, then 5 minutes of the respective maneuver (talk/cough) during which aerosols were continuously sampled through a six-stage Andersen Cascade Impactor (Thermo Fisher Scientific), followed by 2 minutes of tidal breathing. Participants then completed a 5-point comfort rating score (26) and provided comments regarding mask wear during coughing. Masks were weighed before and immediately after each maneuver.
Clinical Measurements
Demographic and clinical measurements were recorded, including age, sex, body mass index (BMI), and intravenous antibiotic use in the week before measurement. A sputum sample was collected on the study day. Spirometry (FEV 1 and FVC) was performed according to American Thoracic Society/European Respiratory Society standards (27) , and the Global Lung Index predicted scale (28) was applied.
Microbiology
Standardized qualitative and quantitative sputum cultures were performed as previously described (20) . P. aeruginosa identification was confirmed by oxidase testing, 42 8 C growth, and matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry. P. aeruginosa genotyping was undertaken using the iPLEX20SNP assay (Sequenom) as previously described (29) .
Statistical Analysis
A sample size calculation based on our earlier work (20) suggested 21 patients were required to demonstrate a 40% reduction in the presence or absence of P. aeruginosa with 80% power and a two-tailed P value of 0.05. Therefore, 25 patients with CF and chronic P. aeruginosa were enrolled, allowing for 10 to 15% dropout to achieve a sample size of 21. IBM SPSS version 22 software (IBM) was used for statistical analysis. Categorical variable associations were examined using Fisher's exact test. Continuous variables describing participant characteristics were examined using Student's t test. Clinical and demographic variables were compared with the log-transformed total P. aeruginosa aerosol colony-forming units (CFUs) in the uncovered cough maneuver using Pearson's correlation test.
A paired t test based on log-transformed CFUs was used to compare each intervention maneuver with the reference maneuver (uncovered cough). Results were stratified by the level of aerosol production as follows: Participants were classed as high, low, or nil viable aerosol producers during the uncovered cough maneuver using arbitrary predefined total CFUs of greater than or equal to 10 (high) or less than 10 (low), respectively, accumulated across the six stages of the Andersen Cascade Impactor (Figure 1 ). The Mann-Whitney U test was used to examine change in mask weight. McNemar's test was used for matched pairs to compare comfort scores for the two mask types.
Results
Participant Overview
Twenty-five (15 male) adult participants with a mean (SD) age of 31.3 years (7.8), FEV 1 percent predicted of 50.7% (17.4), and BMI of 22.1 kg/m 2 (2.8) were recruited (Table 1) . Twenty-two (88%) participants were receiving maintenance azithromycin. Eleven (44%) participants were established on chronic inhaled antibiotic therapy (either continuous or cycling alternate months), and the remaining 14 (56%) participants had been prescribed inhaled antibiotic therapy (less frequently than alternate months) in the 12 months before the study. Eleven participants (44%) had received intravenous antibiotics in the week before their study involvement. The mean (SD) age, FEV 1 percent predicted, and BMI of patients attending TPCH ACFC in 2015 were 30.7 years (9.9), 66.7% (24.1) predicted, and 23.0 kg/m 2 (4.2), respectively. In the preceding calendar year, of 282 patients reviewed at TPCH ACFC, 68.4% had chronic P. aeruginosa infection.
Sputum Microbiology
P. aeruginosa was cultured from the 24 sputum samples provided at a mean concentration of 6.3 3 10 7 cfu/ml (95% confidence interval, 2.6 3 10 7 to 15.0 3 10 7 ) ( Table 1) . Genotyping identified 12 different P. aeruginosa strains, including 5 common Australian shared strains (11) (AUST-01 [n = 6], AUST-02 [n = 9], AUST-06 [n = 6], AUST-07 [n = 3], and AUST-13 [n = 1]), 5 other minor shared strains, and 2 unique strains. Eight participants harbored more than one P. aeruginosa strain; two different strains were detected in seven participants, whereas one participant was infected with three major Australian shared strains (AUST-01, AUST-02, and AUST-06). Other CF pathogens identified in the sputum on the testing day comprised Stenotrophomonas maltophilia (n = 3), Aspergillus fumigatus (n = 3), Haemophilus influenzae (n = 1), and B. cenocepacia (n = 1). Five participants had a history of intermittent Staphylococcus aureus infection in the 12 months before the study, but S. aureus was not isolated from sputum of participants on the day of testing.
Aerosol Sampling
Uncovered cough maneuver. Of the 25 participants, 19 (76%) produced aerosols containing viable P. aeruginosa in the uncovered cough maneuver at 2 meters ( Table 2 ). The participant unable to produce a sputum sample was one of the six who did not culture P. aeruginosa on the cough aerosol plates. Molecular typing revealed that for 16 individuals, the P. aeruginosa genotypes detected in the individual's cough Uncovered cough maneuver n=25
Low viable producers <10 total CFU n=5
High viable producers ≥10 total CFU n=14 Figure 1 . Results of the uncovered cough (reference) maneuver. CFU = colony-forming units; P. aeruginosa = Pseudomonas aeruginosa.
aerosols were genetically indistinguishable from those isolated in their matched sputum samples. Three other participants (two with one indistinguishable P. aeruginosa genotype in their matched aerosol/sputum combination and one with two indistinguishable P. aeruginosa strains in their matched aerosol/sputum combination) were each found to have one additional P. aeruginosa strain in their aerosol cultures that was not detected in their sputum. The three participants who had isolated S. maltophilia in their sputum also generated aerosols that grew this organism (confirmed by matrix-assisted laser desorption/ ionization-time-of-flight mass spectrometry). When the total P. aeruginosa CFUs of uncovered cough aerosols were associated with demographic, clinical, and microbiological parameters, a statistically significant correlation was identified only between log-transformed sputum P. aeruginosa counts and total aerosol load (r = 0.55, P = 0.01). The mean (SD) percentage of culturable particles within the respirable size range (<4.7 mm, collected on Andersen Cascade Impactor stages 3-6) were 71% (27) in the uncovered cough maneuver and 86% (30) in the cough etiquette maneuver (P = 0.21).
Talk maneuvers. No aerosol CFUs were recovered from either talk maneuvers for 23 of 24 (96%) participants, and a single aerosol P. aeruginosa CFU was cultured from the remaining two participants (one masked and one unmasked study) ( Table 2) .
Face masks and cough etiquette maneuvers. Of the 19 participants who produced culture-positive aerosols during uncovered coughing, 2 (11%) produced P. aeruginosa-positive aerosols while wearing the surgical mask, and 4 (21%) grew P. aeruginosa in their aerosol cultures when wearing the N95 mask (Table 2 ). In contrast, 68% of these participants (n = 13) grew P. aeruginosa in their aerosols using cough etiquette (Table 2) .
High viable aerosol production (total CFUs, >10) was observed in 14 of 19 (74%) participants who cultured at least one CFU in the uncovered cough maneuver. In these participants, a reduction in aerosol P. aeruginosa concentration (log-transformed CFUs) was demonstrated with each strategy ORIGINAL ARTICLE designed to interrupt aerosol dispersal: surgical mask (294%), N95 mask (294%), and cough etiquette (253%). The surgical mask (P , 0.001) and the N95 mask (P , 0.001) were both effective in reducing infectious airborne dispersal compared with uncovered coughing, with cough etiquette providing less reduction in mean P. aeruginosa CFUs than both masks ( Table 3 ). The tolerability of the masks during cough maneuvers varied, with 13 (54%) participants providing a higher comfort rating for the surgical mask than for the N95 mask compared with 2 (8%) who provided a higher comfort rating for the N95 mask and 9 (38%) who had no preference (P = 0.013) ( Table 4 Cough numbers for each maneuver were similar, and there was no difference in the number of coughs during the N95 mask (P = 0.15) and cough etiquette (P = 0.52) tests compared with the uncovered coughing intervention (see Table E1 in the online supplement), indicating that fatigue or participant motivation was unlikely to have impacted the accuracy of the maneuvers.
Infection Control
P. aeruginosa or other CF pathogens were not cultured from blank aerosol tests or surface swabs of the tunnel.
Adverse Events
Overall, the maneuvers were well tolerated; however, one participant (listed for lung transplant and FEV 1 32.5% predicted) discontinued the N95 mask study owing to claustrophobia and increased dyspnea after mask application.
Discussion
This study demonstrates that at 2 meters from the source, both surgical and N95 masks are highly effective in reducing aerosols containing viable P. aeruginosa in the droplet nuclei size range during voluntary coughing in people with CF. Our study uses a system that mimics a hospital environment and has several strengths. It was designed to reflect real-world occurrences by using a model that allows determination of air contamination at the recommended separation distance between people with CF and by investigating the effect of cough etiquette and two commonly available masks in hospitals on aerosol dispersal. The cough maneuvers examined may also closely replicate aerosol production during airway clearance sessions and spirometry procedures. Furthermore, we provide much-needed information on the short-term tolerability of mask wearing by persons with lung disease, which is an oftenoverlooked dimension of infection control.
Cross-infection between people with CF has increasingly been reported over the past 2 decades, initially with B. cepacia complex (30, 31) , P. aeruginosa (9-11), and more recently Mycobacterium abscessus (15, 32) . Progressive changes to infection control policies have been implemented, including cohort segregation and changes to practice for patients with CF in the clinic and inpatient facility. Airborne transmission of CF pathogens in aerosol droplet nuclei has been suggested, and such evidence has contributed to the enhanced rigor of these policies (17, 18) . Increased separation distance between people with CF and the wearing of surgical masks during hospital visits are now recommended (21) . Evidence to support the effectiveness of the latter strategy has been limited. Researchers in two previous studies evaluated the effect of surgical mask wearing on bioaerosol spread within a CF cohort. Our finding of a strong protective effect with surgical masks during cough maneuvers corroborate and strengthen the findings of Driessche and colleagues, who demonstrated an 86% reduction in environmental detection of airborne P. aeruginosa concentration during mask wearing compared with the reference group (coughing without a surgical mask) in a controlled laboratory model (33) . In contrast, Zuckerman and colleagues found no difference in rates of air contamination of outpatient examination rooms between mask-wearing and unmasked patients with CF, although the overall positive air sample yield was low, including in the control group without masks (0.7%) (34) .
Three-fourths of the participants who were studied produced aerosols containing viable P. aeruginosa at 2 meters during uncovered coughing. The only predictor of expired aerosol containing viable bacteria was the sputum load of P. aeruginosa, which agrees with the results of our earlier work (20) , further suggesting that burden of infection is a very important determinant of potential infectiousness. A previous study using artificially generated aerosols demonstrated that P. aeruginosa respiratory samples with a mucoid phenotype exhibited improved survival, although this advantage did not extend to epidemic strains (35) . The aerosol samples from the uncovered cough maneuvers in our study revealed both unique and shared Australian strains of P. aeruginosa, but the overall numbers were too small to draw any conclusions regarding survival characteristics.
To date, very few studies have directly compared the performance of various respiratory hygiene strategies in vivo, and, to our knowledge, the present study is the first in which the outward protective effects of various interventions in a CF population with chronic P. aeruginosa infection have been investigated. We have demonstrated that surgical and N95 masks both significantly reduce the potential for bioaerosol dispersal with greater than 90% reduction in the mean total CFUs. Previous evidence suggested that impaction of microbe-laden droplets directly onto an obstruction such as a hand or surgical mask during coughing limits the formation of airborne droplet nuclei (36) . Our findings support this suggestion. Likewise, in an earlier study, researchers also found that surgical and N95 masks were equally effective in interrupting aerosol transmission of influenza in nine patients (37) . Researchers in a different study considered the impact of cough etiquette strategies (including the hand, a tissue, an arm) on preventing cough aerosols in healthy volunteers (38) . Similarly to us, they reported that the expelled cough aerosol was not completely blocked by cough etiquette, therefore posing a potential risk for airborne transmission (38) . Importantly, the majority of viable aerosol detected during uncovered coughing in the present study was in the respirable size range (,4.7 mm), and this was not significantly different for the cough etiquette maneuver. Our study also demonstrates that talking is a low infectious aerosol-producing activity, potentially indicating that the implementation of mask policies for people with CF within the hospital should especially target relevant high-risk clinical settings. During times of known high aerosol-producing activities (performing spirometry and airway clearance) in the clinical setting when a mask is not feasible, other considerations such as high air exchange rates, negative pressure rooms, and/or adequate washout time periods between patients in individual rooms is important.
Although short mask wear duration was overall well tolerated by people with CF, it was perceived by the participants as being less comfortable than wearing no mask, particularly the N95 mask, where additional outward protection was not observed. This may be an important factor when considering adherence to correct wearing technique, especially over extended periods. In healthy subjects and healthcare professionals, the use of face masks has been associated with increased breathing resistance (39), headaches (40) , and physical discomfort (41, 42) , and tolerability lessens with increased duration of wear (43) . Furthermore, the physiological effects and comfort of mask wear among people with respiratory conditions has not been studied extensively and may have an adverse impact. In one study in which investigators compared surgical and N95 mask efficacy in patients with confirmed influenza, the researchers reported that 1 participant (among a cohort of 10) was unable to complete the short protocol owing to respiratory distress (37) . However, Dharmadhikari and colleagues (44) investigated the clinical efficacy of surgical masks over extended periods in patients with multidrug-resistant tuberculosis and demonstrated a 56% reduction in transmission risk. Patients wore surgical masks for up to 12 hours, with permitted interruptions for meals and medication, although it was reported that patients with respiratory distress were not enrolled in the study and incentives were used to encourage adherence. The tolerability of mask wear in people with respiratory infection and lung disease is an area that requires further investigation.
High rates of mask interference by the wearer have been reported in people with CF in the outpatient setting (34) . In our study, the participants were unable to touch or readjust the masks during the testing period because the arms were positioned outside the tunnel. However, mask movement and slippage during the coughing maneuvers were observed for some participants. In fact, it was noted that three of the four participants who had detectable P. aeruginosa CFUs in the N95 mask cough maneuver experienced mask movement, which may have led to an ineffective facial seal and contributed to the release of viable aerosol.
The participants in this study comprised an adult cohort with moderate to severe lung disease. On the basis of earlier data demonstrating a strong correlation between P. aeruginosa sputum density and cough aerosol concentration (18, 20) , sputumproducing participants were enrolled as a robust means of assessing mask efficacy within the clinical setting. Our results nevertheless highlight the need for additional studies to determine the role and effectiveness of masks in CF pediatric populations or for those with preserved lung function and/or those who rarely expectorate sputum. Despite this, there are some important caveats to consider. First, one participant in the present study did not produce a sputum sample and, importantly, was one of the six participants who did not culture P. aeruginosa in their cough aerosol. However, our earlier data demonstrated that nonproductive patients can produce viable aerosols (18, 20) . Second, quantitative sputum microbiology is not routinely performed in most CF centers serviced by clinical microbiology laboratories. Third, other clinical parameters do not predict viable aerosol production (18, 20) . Fourth, the infective inoculum of P. aeruginosa (or other CF pathogens) is not known, and therefore we cannot estimate the extent of infection risk for an individual after single (or for that matter multiple) episodes of exposure to cough aerosols. We suggest that, taken together, a universal maskwearing approach across both adult and pediatric CF centers should be strongly considered to mitigate the risk of personto-person spread of CF pathogens.
Limitations of our study include that the application and check of mask fit by a The boldfaced data represent participants (n = 9) who reported no preference for the comfort of the surgical mask or the N95 mask. Numbers to the right of the boldfaced data represent participants (n = 2) who provided a higher comfort rating for the N95 mask and those to the left represent participants (n = 13) who provided a higher comfort rating for the surgical mask. *Comfort level categories: 1 (very poor), 2 (poor), 3 (sufficient), 4 (good), and 5 (very good). A low number of responses were obtained in the 1 (very poor) and 5 (very good) categories; therefore, for the analysis, the categories of 1 (very poor) and 2 (poor) were combined ("poor"), as were the categories of 4 (good) and 5 (very good) ("good").
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healthcare professional and the short maskwearing duration of less than 10 minutes may not reflect the typical application in a clinical setting; therefore, the study may overestimate the protective effect of face masks. Furthermore, the cough etiquette technique adopted by participants differed widely, which may impact the results but does allow a more real-world situation. The culture media used in the Andersen Cascade Impactors and incubation conditions were selective for nonfastidious aerobic gramnegative bacteria and did not allow the investigation of cough aerosol viability of other CF pathogens such as H. influenzae, S. aureus, and nontuberculous mycobacteria. Whereas we focused specifically on P. aeruginosa in this study, our earlier work demonstrated similar findings of viable aerosols of common CF pathogens (18, 20) ; thus, it is likely that the effectiveness of masks would generalize to other bacteria in people with CF. Finally, compared with the clinically stable patients, we observed a greater proportion of participants receiving intravenous antibiotics for pulmonary exacerbations who were low viable aerosol producers. However, the present study was not powered to examine the impact of clinical status (clinical stability vs. pulmonary exacerbation) and antimicrobial therapies on viable aerosol production. Further studies are required to address this clinically important question.
In conclusion, masks are a simple and relatively inexpensive method of effectively interrupting aerosol dispersal of P. aeruginosa in droplet nuclei generated during coughing in people with CF, with the surgical mask providing enhanced wearer comfort. These data support the Cystic Fibrosis Foundation Infection Prevention and Control Guidelines recommending that individuals with CF wear a surgical mask to reduce environmental contamination and potential viable aerosol spread associated with coughing in communal areas of health facilities (21) . Cough etiquette reduces viable bacterial aerosols, but not to the same extent as masks. Future studies will assess whether mask application by the wearer and a longer duration of mask wear in a CF cohort impacts wearer tolerability and mask effectiveness. n Author disclosures are available with the text of this article at www.atsjournals.org.
